Abstract
Locoregional techniques have become the mainstay of therapy for patients with unresectable hepatocellular carcinoma (HCC). Such image-guided interventions include catheter-based approaches (transarterial chemoembolization and yttrium-90 radiotherapy) and locoregional ablative techniques, either chemical (percutaneous ethanol injection), or thermal (radiofrequency ablation, laser ablation, microwave ablation and cryoablation). These therapies are mainly utilized for palliation, but have also been used with curative intent. In selected cases, percutaneous interventional treatments have shown good results (5-year survival 40–50%), but, even when chosen as first-line treatment, have not been able to achieve the response rates and outcomes achieved by surgical options (resection or transplantation). New promising image-guided therapies are continuously emerging, as we attempt to improve tumor targeting, minimize hepatic toxicity and ultimately improve quality of life and survival of patients with HCC. With new technologies in imaging and drug delivery becoming available, it is likely that, in the future, patients with HCC will be best treated by a multidisciplinary team approach, utilizing a combination of techniques to improve patient survival. This review outlines the current status of the most commonly used image-guided locoregional interventions in the treatment of patients with HCC, and describes recent research and advances related to image-guided interventions for liver cancer.
Key Points
-
Locoregional techniques have become the mainstay of therapy for patients with unresectable hepatocellular carcinoma.
-
Such image-guided interventions include catheter-based approaches (transarterial chemoembolization, yttrium-90 radiotherapy) and locoregional ablative techniques, either chemical (percutaneous ethanol injection), or thermal (radiofrequency ablation, laser ablation, microwave ablation)
-
These therapies are mainly utilized for palliation, but also been used with curative intent. In selected cases, percutaneous interventional treatments have shown good results (5-year survival 40–50%), but have not been able to achieve the response rates and outcomes achieved by surgical options, even when chosen as first-line treatment
-
New promising image-guided therapies and imaging and drug delivery techniques are continuously emerging, to improve tumor targeting, minimize hepatic toxicity and ultimately improve quality of life and survival of patients
-
It is likely that, in the future, patients with hepatocellular carcinoma will best be treated by a multidisciplinary team approach, using a combination of techniques to improve patient survival
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Stuart KE et al. (1996) Hepatocellular carcinoma in the United States: prognostic features, treatment outcome, and survival. Cancer 77: 2217–2222
Okuda K et al. (1985) Natural history of hepatocellular carcinoma and prognosis in relation to treatment: study of 850 patients. Cancer 56: 918–928
Bruix J et al. (2005) Practice Guidelines Committee, American Association for the Study of Liver Diseases: management of hepatocellular carcinoma. Hepatology 42: 1208–1236
Bismuth H et al. (1986) Liver resection in cirrhotic patients: a western experience. World J Surg 10: 311–316
Livraghi T et al. (1995) Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 197: 101–108
Llovet JM and Bruix J (2003) Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37: 429–442
Llovet JM et al. (2003) Hepatocellular carcinoma. Lancet 362: 1907–1917
Geschwind JF (2002) Chemoembolization for hepatocellular carcinoma: where does the truth lie? J Vasc Interv Radiol 13: 991–994
Geschwind JF et al. (2003) Chemoembolization of hepatocellular carcinoma: results of a metaanalysis. Am J Clin Oncol 26: 344–349
[No authors listed] (1995) A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire. N Engl J Med 332: 1256–1261
Lo CM et al. (2002) Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35: 1164–1171
Llovet JM et al. (2002) Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359: 1734–1739
Graziadei IW et al. (2003) Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl 9: 557–563
Hayashi PH et al. (2004) Hepatic artery chemoembolization for hepatocellular carcinoma in patients listed for liver transplantation. Am J Transplant 4: 782–787
Livraghi T et al. (2004) Multimodal image-guided tailored therapy of early and intermediate hepatocellular carcinoma: long-term survival in the experience of a single radiologic referral center. Liver Transpl 10 (Suppl 1): S98–S106
Bruix J et al. (2004) Chemoembolization for hepatocellular carcinoma. Gastroenterology 127 (Suppl 1): S179–S188
Simonetti RG et al. (1997) Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials. Ann Oncol 8: 117–136
Xiong ZP et al. (2004) Association between vascular endothelial growth factor and metastasis after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 3: 386–390
Kobayashi N et al. (1999) Co-expression of Bcl-2 protein and vascular endothelial growth factor in hepatocellular carcinomas treated by chemoembolization. Liver 19: 25–31
Jaeger HJ et al. (1996) Sequential transarterial chemoembolization for unresectable advanced hepatocellular carcinoma. Cardiovasc Intervent Radiol 19: 388–396
Qian J et al. (2003) Application of poly-lactide-co-glycolide-microspheres in the transarterial chemoembolization in an animal model of hepatocellular carcinoma. World J Gastroenterol 9: 94–98
Constantin M et al. (2004) Preparation and characterisation of poly(vinyl alcohol)/cyclodextrin microspheres as matrix for inclusion and separation of drugs. Int J Pharm 285: 87–96
Geschwind JF et al. (2005) New intra-arterial drug delivery system: pharmacokinetics and tumor response in an animal model of liver cancer: 41st Annual Meeting of the American Society of Clinical Oncology, May 2005, Orlando, Florida
Varela M (2005) Presented at 56th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) November 2005, San Francisco, California
Geschwind JF et al. (2004) Yttrium-90 microspheres for the treatment of hepatocellular carcinoma. Gastroenterology 127 (Suppl 1): S194–S205
Lau WY et al. (1994) Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study. Br J Cancer 70: 994–999
Ho S et al. (1998) Internal radiation therapy for patients with primary or metastatic hepatic cancer: a review. Cancer 83: 1894–1907
Raoul JL et al. (1994) Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support. J Nucl Med 35: 1782–1787
Raoul JL et al. (1997) Prospective randomized trial of chemoembolization versus intra-arterial injection of 131I-labeled-iodized oil in the treatment of hepatocellular carcinoma. Hepatology 26: 1156–1161
Okuda K (1993) Intratumor ethanol injection. J Surg Oncol Suppl 3: S97–S99
Hasegawa S et al. (1999) Factors that predict intrahepatic recurrence of hepatocellular carcinoma in 81 patients initially treated by percutaneous ethanol injection. Cancer 86: 1682–1690
De Sanctis JT (1998) Percutaneous treatment of hepatic neoplasms: a review of current techniques. Cardiovasc Intervent Radiol 21: 273–296
Livraghi T et al. (1995) No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis: Italian Cooperative HCC Study Group. J Hepatol 22: 522–526
Livraghi T et al. (2001) Radiofrequency thermal ablation of hepatocellular carcinoma. Eur J Ultrasound 13: 159–166
Goldberg SN et al. (1995) Tissue ablation with radiofrequency using multiprobe arrays. Acad Radiol 2: 670–674
Siperstein AE et al. (1997) Laparoscopic thermal ablation of hepatic neuroendocrine tumor metastases. Surgery 122: 1147–1154
Miao Y et al. (1997) Ex vivo experiment on radiofrequency liver ablation with saline infusion through a screw-tip cannulated electrode. J Surg Res 71: 19–24
Patterson EJ et al. (1998) Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size. Ann Surg 227: 559–565
Goldberg SN et al. (1998) Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis? J Vasc Interv Radiol 9: 101–111
Wiersinga WJ et al. (2003) Lesion progression with time and the effect of vascular occlusion following radiofrequency ablation of the liver. Br J Surg 90: 306–312
Tanabe KK et al. (2004) Radiofrequency ablation: the experts weigh in. Cancer 100: 641–650
Choi D et al. (2004) Recurrent hepatocellular carcinoma: percutaneous radiofrequency ablation after hepatectomy. Radiology 230: 135–141
Lencioni R et al. (2003) Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 228: 235–240
Lencioni R et al. (2005) Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234: 961–967
Lin SM et al. (2004) Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma ≤4 cm. Gastroenterology 127: 1714–1723
Tateishi R et al. (2005) Percutaneous radiofrequency ablation for hepatocellular carcinoma: an analysis of 1000 cases. Cancer 103: 1201–1209
Hong SN et al. (2005) Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function. J Clin Gastroenterol 39: 247–252
Llovet JM et al. (2001) Barcelona Clinic Liver Cancer (BCLC) Group: increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 33: 1124–1129
Livraghi T et al. (2005) Risk of tumour seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma. Br J Surg 92: 856–858
Jaskolka JD et al. (2005) Needle tract seeding after radiofrequency ablation of hepatic tumors. J Vasc Interv Radiol 16: 485–491
de Baere T et al. (2003) Adverse events during radiofrequency treatment of 582 hepatic tumors. Am J Roentgenol 181: 695–700
Sotomayor R and Ravikumar TS (1996) Cryosurgery on the treatment of hepatic tumors. Cancer Control 3: 414–420
Dick EA et al. (2002) Ablative therapy for liver tumours. Gut 50: 733–739
Seifert JK and Morris DL (1999) World survey on the complications of hepatic and prostate cryotherapy. World J Surg 23: 109–113
Murakami R et al. (1995) Treatment of hepatocellular carcinoma: value of percutaneous microwave coagulation. Am J Roentgenol 164: 1159–1164
Head HW and Dodd GD III (2004) Thermal ablation for hepatocellular carcinoma. Gastroenterology 127 (Suppl 1): S167–S178
Shibata T et al. (2002) Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology 223: 331–337
Horigome H et al. (1999) Standards for selecting percutaneous ethanol injection therapy or percutaneous microwave coagulation therapy for solitary small hepatocellular carcinoma: consideration of local recurrence. Am J Gastroenterol 94: 1914–1917
Seki T et al. (1999) Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: comparison with percutaneous ethanol injection therapy. Cancer 85: 1694–1702
Liang P et al. (2005) Prognostic factors for survival in patients with hepatocellular carcinoma after percutaneous microwave ablation. Radiology 235: 299–307
Giorgio A et al. (2000) Interstitial laser photocoagulation under ultrasound guidance of liver tumors: results in 104 treated patients. Eur J Ultrasound 11: 181–188
Pacella CM et al. (2001) Laser thermal ablation in the treatment of small hepatocellular carcinoma: results in 74 patients. Radiology 221: 712–720
Kitamoto M et al. (2003) Radiofrequency ablation in the treatment of small hepatocellular carcinomas: comparison of the radiofrequency effect with and without chemoembolization. Am J Roentgenol 181: 997–1003
Therasse P et al. (2002) New guidelines to evaluate the response to treatment in solid tumors: European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92: 205–216
Lim HK and Han JK (2002) Hepatocellular carcinoma: evaluation of therapeutic response to interventional procedures. Abdom Imaging 27: 168–179
Takayasu K et al. (2000) Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma. Am J Roentgenol 175: 699–704
De Santis M et al. (1993) MRI of hepatocellular carcinoma before and after transcatheter chemoembolization. J Comput Assist Tomogr 17: 901–908
Bruix J et al. (2001) Clinical management of hepatocellular carcinoma: conclusions of the Barcelona-2000 EASL conference: European Association for the Study of the Liver. J Hepatol 35: 421–430
Kamel IR et al. (2003) Role of diffusion-weighted imaging in estimating tumor necrosis after chemoembolization of hepatocellular carcinoma. Am J Roentgenol 181: 708–710
Lin DY et al. (1988) Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma—a randomized controlled trial. Gastroenterology 94: 453–456
Pelletier G et al. (1990) A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol 11: 181–184
Pelletier G et al. (1998) Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial: Groupe CHC. J Hepatol 29: 129–134
Rossi S et al. (1996) Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. Am J Roentgenol 167: 759–768
Nicoli N et al. (2000) Intraoperative and percutaneous radiofrequency thermal ablation in the treatment of hepatocellular carcinoma. Chir Ital 52: 29–40
Buscarini L et al. (2001) Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results. Eur Radiol 11: 914–921
Iannitti DA et al. (2002) Hepatic radiofrequency ablation. Arch Surg 137: 422–426
Raut CP et al. (2005) Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis. Ann Surg Oncol 12: 616–628
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
J-FH Geschwind is a consultant for MDS Nordian, Biocomptibles Int. Biospheres Medical. He receives research support from MDS Nordian.
Rights and permissions
About this article
Cite this article
Hong, K., Georgiades, C. & Geschwind, JF. Technology Insight: image-guided therapies for hepatocellular carcinoma—intra-arterial and ablative techniques. Nat Rev Clin Oncol 3, 315–324 (2006). https://doi.org/10.1038/ncponc0512
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncponc0512
This article is cited by
-
MR Imaging of Therapeutic Magnetic Microcarriers Guided by Magnetic Resonance Navigation for Targeted Liver Chemoembolization
CardioVascular and Interventional Radiology (2014)
-
Tumor Uptake of Hollow Gold Nanospheres After Intravenous and Intra-arterial Injection: PET/CT Study in a Rabbit VX2 Liver Cancer Model
Molecular Imaging and Biology (2013)
-
Clinical Application of Image-Enhanced Minimally Invasive Robotic Surgery for Gastric Cancer: A Prospective Observational Study
Journal of Gastrointestinal Surgery (2013)
-
Chemoembolization and Radioembolization for Metastatic Disease to the Liver: Available Data and Future Studies
Current Treatment Options in Oncology (2012)
-
Transvaskuläre Ablation des hepatozellulären Karzinoms
Der Radiologe (2012)